Normal interleukin-10 serum level opposed to high serum levels of carbohydrate antigen 19-9 and cancer antigens 125 and 50 in a case of true splenic cyst

Archives of Medical Research

Volumn 34, Issue 2, 2003, Pages 145-148

  Lieto, Eva ^a   Castellano, Paolo ^a   Ferraraccio, Francesca ^a   Orditura, Michele ^a   De Vita, Ferdinando ^a   Romano, Ciro ^a   Pignatelli, Carlo ^a   Galizia, Gennaro ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Carbohydrate antigen 19 9; Interleukin 10; True splenic cysts; Tumor markers

Indexed keywords

CA 125 ANTIGEN; CA 19-9 ANTIGEN; CA 50 ANTIGEN; INTERLEUKIN 10; TUMOR MARKER;

ABDOMINAL INJURY; ABDOMINAL MASS; ABDOMINAL PAIN; ADULT; ANAMNESIS; ARTICLE; BLOOD LEVEL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CYSTADENOCARCINOMA; DISEASE COURSE; ECHOGRAPHY; EPITHELIUM; FEMALE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MALIGNANT NEOPLASTIC DISEASE; OVARIECTOMY; OVARY TUMOR; PROTEIN BLOOD LEVEL; SPLEEN CYST; SPLENECTOMY; WEIGHT REDUCTION;

EID: 0037359988     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0188-4409(02)00468-X     Document Type: Article

References (25)

1. López J.B., Royan G.P., Lakhwani M.N., Mahadaven M., Timor J. CA 72-4 compared with CEA and CA 19-9 as a marker of some gastrointestinal malignancies. Int J Biol Markers. 14:1999;172-177.
2. Mann D.V., Edwards R., Ho S., Lau W.Y., Glazer G. Elevated tumour marker CA19-9. clinical interpretation and influence of obstructive jaundice Eur J Surg Oncol. 26:2000;474-479.
3. Halm U., Schumann T., Schiefke I., Witzigmann H., Mossner J., Keim V. Decrease of CA 19-9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer. Br J Cancer. 82:2000;1013-1016.
4. Ito S., Gejyo F. Elevation of serum CA19-9 levels in benign diseases. Intern Med. 38:1999;840-841.
5. Kim H.J., Kim M.H., Myung S.J., Lim B.C., Park E.T., Yoo K.S., Seo D.W., Lee S.K., Min Y.I. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer. analysis using a receiver operating characteristic curve Am J Gastroenterol. 94:1999;1941-1946.
6. Terada T., Yasoshima M., Yoshimitsu Y., Nakanuma Y. Carbohydrate antigen 19-9 producing giant epithelial cyst of the spleen in a young woman. J Clin Gastroenterol. 18:1994;57-61.
7. Walz M.K., Metz K.A., Sastry M., Eigler F.W., Leder L.D. Benign mesothelial splenic cyst may cause high serum concentration of CA 19-9. Eur J Surg. 160:1994;389-391.
8. Yoshikane H., Suzuki T., Yoshioka N., Ogawa Y., Hayashi Y., Hamajima E., Yokoi T. Giant splenic cyst with high serum concentration of CA 19-9. Failure of treatment with percutaneous transcatheter drainage and injection of tetracycline. Scand J Gastroenterol. 31:1996;524-526.
9. Decker D., Bollmann R., Hirner A., Stratmann H. Increased CA-19-9 caused by a splenic cyst. a rare differential diagnosis Zentralbl Chir. 123:1998;855-857.
10. Higaki K., Jimi A., Watanabe J., Kusaba A., Kojiro M. Epidermoid cyst of the spleen with CA19-9 or carcinoembryonic antigen productions. report of three cases Am J Surg Pathol. 22:1998;704-708.
11. Sardi A., Ojeda H.F., King D. Jr. Laparoscopic resection of a benign true cyst of the spleen with the harmonic scalpel producing high levels of CA 19-9 and carcinoembryonic antigen. Am Surg. 64:1998;1149-1154.
12. Ishibashi R., Sakai T., Yamashita Y., Maekawa T., Hideshima T., Shirakusa T. Benign epithelial cyst of the spleen with a high production of carbohydrate antigen 19-9. Int Surg. 84:1999;151-154.
13. Sakamoto Y., Yunotani S., Edakuni G., Mori M., Iyama A., Miyazaki K. Laparoscopic splenectomy for a giant splenic epidermoid cyst. report of a case Surg Today. 29:1999;1268-1272.
14. van Lacum M.W., Hessels R.A., Kremer G.D., Jaspers C.A. A splenic cyst and a high serum CA 19-9. a case report Eur J Intern Med. 11:2000;104-107.
15. Soudack M., Ben-Nun A., Toledano C. Elevated carbohydrate antigen 19-9 in patients with true (epithelial) splenic cysts - rare or undiscovered? Can J Gastroenterol. 15:2001;125-126.
16. Trompetas V., Panagopoulos E., Priovolou-Papaevangelou M., Ramantanis G. Giant benign true cyst of the spleen with high serum level of CA 19-9. Eur J Gastroenterol Hepatol. 14:2002;85-88.
17. McLaughlin R., O'Hanlon D., Kerin M., Kenny P., Grimes H., Given H.F. Are elevated levels of the tumour marker CA19-9 of any clinical significance? An evaluation. Ir J Med Sci. 168:1999;124-126.
18. De Vita F., Orditura M., Galizia G., Romano C., Lieto E., Iodice P., Tuccillo C., Catalano G. Serum interleukin-10 is an independent prognostic factor in advanced solid tumors. Oncol Rep. 7:2000;357-361.
19. De Vita F., Orditura M., Galizia G., Romano C., Infusino S., Auriemma A., Lieto E., Catalano G. Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies. Cancer. 86:1999;1936-1943.
20. Sternberger L.A., Sternberger N.H. The unlabeled antibody method. comparison of peroxidase-antiperoxidase with avidin-biotin complex by a new method of quantification J Histochem Cytochem. 34:1986;599-605.
21. Williams R.J., Glazer G. Splenic cysts. changes in diagnosis, treatment and aetiological concepts Ann R Coll Surg Engl. 75:1993;87-89.
22. de Melo V.A., Alves A. Jr., Andrade L.C., Aragao J.F., Rosa J.E. Splenic cyst. Review of the literature and report of 2 cases. Rev Hosp Clin Fac Med Sao Paulo. 50:1995;289-293.
23. Galizia G., Lieto E., De Vita F., Romano C., Orditura M., Castellano P., Imperatore V., Infusino S., Catalano G., Pignatelli C. Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery. relationship with radicality and outcome J Interferon Cytokine Res. 22:2002;473-482.
24. Rohr S., Trombetta V., Maloisel F., Becmeur F., Chenard M.P., Meyer C. True benign non-parasitic cysts of the spleen. from diagnosis to treatment. A propos of 5 new cases J Chir. 132:1995;467-471.
25. Seshadri P.A., Poulin E.C., Mamazza J., Schlachta C.M. Needlescopic decapsulation of a splenic epithelial cyst. Can J Surg. 43:2000;303-305.